These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16314631)

  • 61. Use of molecular imaging to differentiate liver metastasis of colorectal cancer metastasis from neuroendocrine tumor origin.
    Desai K; Watkins J; Woodward N; Quigley AM; Toumpanakis C; Bomanji J; Caplin M
    J Clin Gastroenterol; 2011 Jan; 45(1):e8-11. PubMed ID: 20861802
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Positron emission tomography and colorectal cancer.
    Lin M; Wong K; Ng WL; Shon IH; Morgan M
    Crit Rev Oncol Hematol; 2011 Jan; 77(1):30-47. PubMed ID: 20619671
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer.
    Burt BM; Humm JL; Kooby DA; Squire OD; Mastorides S; Larson SM; Fong Y
    Neoplasia; 2001; 3(3):189-95. PubMed ID: 11494112
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor.
    Seto J
    J Nucl Med; 2009 Jan; 50(1):167; author reply 168. PubMed ID: 19091904
    [No Abstract]   [Full Text] [Related]  

  • 65. Perfusion of colorectal liver metastases and uptake of fluorouracil assessed by H2(15)O and [18F]uracil positron emission tomography (PET).
    Hohenberger P; Strauss LG; Lehner B; Frohmüller S; Dimitrakopoulou A; Schlag P
    Eur J Cancer; 1993; 29A(12):1682-6. PubMed ID: 8398294
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of FDG-PET in detecting rejection after liver transplantation.
    Watson AM; Bhutiani N; Philips P; Davis EG; Eng M; Cannon RM; Jones CM
    Surgery; 2018 Aug; 164(2):257-261. PubMed ID: 29776597
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Observations on the effects of lithium on carcinoid tumors.
    Zanzi I; Warner RR
    Pancreas; 2013 Aug; 42(6):1040-2. PubMed ID: 23851437
    [No Abstract]   [Full Text] [Related]  

  • 68. A novel and efficient synthesis of [2-11C]5-fluorouracil for prognosis of cancer chemotherapy.
    Seki K; Nishijima K; Kuge Y; Tamaki N; Wiebe LI; Ohkura K
    J Pharm Pharm Sci; 2007; 10(2):212-6. PubMed ID: 17706179
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular imaging in management of colorectal metastases by the interventional oncologist.
    Hunt S; Zandifar A; Alavi A
    Int J Hyperthermia; 2022; 39(1):675-681. PubMed ID: 35465814
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Positron emission tomography as an imaging biomarker.
    Weber WA
    J Clin Oncol; 2006 Jul; 24(20):3282-92. PubMed ID: 16829652
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Understanding SUV variability in reference tissue for 18F-FDG PET with a simple measurement model.
    Thie JA
    J Nucl Med; 2014 Feb; 55(2):352. PubMed ID: 24323816
    [No Abstract]   [Full Text] [Related]  

  • 72. [Long-term prognosis for colorectal carcinoma treated with adjuvant immunochemotherapy].
    Sakai T; Yamashita Y
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():460-3. PubMed ID: 14574935
    [No Abstract]   [Full Text] [Related]  

  • 73. Metabolites of 2'-fluoro-2'-deoxy-D-glucose detected by 19F magnetic resonance spectroscopy in vivo predict response of murine RIF-1 tumors to 5-fluorouracil.
    McSheehy PM; Leach MO; Judson IR; Griffiths JR
    Cancer Res; 2000 Apr; 60(8):2122-7. PubMed ID: 10786672
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.
    Xu J; Qin X; Wang J; Zhang S; Zhong Y; Ren L; Wei Y; Zeng S; Wan D; Zheng S; ; ;
    J Cancer Res Clin Oncol; 2011 Sep; 137(9):1379-96. PubMed ID: 21796415
    [No Abstract]   [Full Text] [Related]  

  • 75. Concurrent focal fat sparing and peritumoral fat sparing in diffuse fatty liver identified on 18F-FDG PETCT and multiparametric magnetic resonance imaging.
    Yang M; Hara AK; Nguyen BD; Roarke MC
    Dig Liver Dis; 2017 Oct; 49(10):1164. PubMed ID: 28600027
    [No Abstract]   [Full Text] [Related]  

  • 76. The age of reason for FDG PET image-derived indices.
    Visvikis D; Hatt M; Tixier F; Cheze Le Rest C
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1670-2. PubMed ID: 22968400
    [No Abstract]   [Full Text] [Related]  

  • 77. Systemic cytotoxic and biologic therapies for colorectal cancer liver metastases: expert consensus statement.
    Clary BM; Grothey A; Kopetz S; Marsh RD
    HPB (Oxford); 2013 Feb; 15(2):116-8. PubMed ID: 23297722
    [No Abstract]   [Full Text] [Related]  

  • 78. The AXIS colorectal cancer trial: randomization of over 2000 patients. The AXIS Steering Group.
    Br J Surg; 1994 Nov; 81(11):1672. PubMed ID: 7827904
    [No Abstract]   [Full Text] [Related]  

  • 79. Advancements in the Management of Synchronous Colorectal Liver Metastases: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities.
    Karaoğlan BB; Öz DK; Araz MS; Akyol C; Utkan G
    Curr Oncol Rep; 2024 Jul; 26(7):791-803. PubMed ID: 38776011
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A lesson in humility: the added values of PET-MRI over PET-CT in detecting malignant hepatic lesions.
    Cohen D; Kesler M; Muchnik Kurash M; Even-Sapir E; Levine C
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1423-1433. PubMed ID: 36602558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.